In contrast with this previously presented data, Figure 4 demonstrates that consideration of the overall mutational profile of the cancer must be considered as it could potentially contribute to overexpression of BDP1 through a regulatory network, demonstrating a possible dual role for BDP1 in serous ovarian cancer that is dependent on the overall mutational profile. This evidence concerns the gene BDP1 and ovarian serous adenocarcinoma.